Bulk Orders 20+ bottles
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
GLP Collection
Capsulated GLP Orforglipron is a capsule research product containing 6MG Orforglipron per capsule with 60 capsules per bottle, designed for laboratory investigations involving non-peptide GLP-1 receptor agonist pathway research, incretin signaling, glucose-response biology, insulin pathway...
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkVerified test results
Each batch is analyzed by an independent third-party laboratory before release. The lots below were tested by Chromate and ILS Laboratories. Below is the report for lot 060526, summarized from the certificate the lab published.
Every lot we have published for this compound, grouped by the lab that tested it, newest first. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Encapsulated research material
Capsulated GLP Orforglipron is a capsule research product containing 6MG Orforglipron per capsule with 60 capsules per bottle, designed for laboratory investigations involving non-peptide GLP-1 receptor agonist pathway research, incretin signaling, glucose-response biology, insulin pathway models, appetite-related signaling, energy-balance research, and metabolic adaptation studies.
Disguised Alpha Capsulated GLP is built for researchers studying next-generation GLP pathway systems in a finished oral-format research model. Unlike lyophilized peptide GLP products, Orforglipron is studied as a small-molecule, non-peptide GLP-1 receptor agonist research compound.
Orforglipron represents a different research category than traditional lyophilized GLP peptides. It is studied as a non-peptide GLP-1 receptor agonist in capsule-based models involving incretin signaling, metabolic regulation, glucose-response biology, and energy-balance pathway research.
| Compound | Orforglipron |
|---|---|
| Strength | 6MG per capsule |
| Count | 60 capsules |
| Format | finished capsule research product |
Studied as a small-molecule GLP-1 receptor agonist research compound rather than a lyophilized peptide format.
Orforglipron is studied as a non-peptide GLP-1 receptor agonist research compound with interest in incretin signaling, glucose-response biology, insulin pathway models, appetite-related signaling, gastric-emptying-related research, energy-balance regulation, and metabolic adaptation.
Because Orforglipron is studied in capsule-based small-molecule research models, it gives researchers a different comparison point from lyophilized GLP peptides such as GLP1-Sema, GLP2-Tirz, or GLP3-Reta.
This makes Capsulated GLP especially relevant for researchers comparing peptide-based incretin models with non-peptide GLP-1 receptor pathway systems.
Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.
Characterized a nonpeptide GLP-1 receptor agonist. Orforglipron is a small molecule and should not be described as encapsulated semaglutide.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
It is the stated quantity per unit, separate from the number of units in the bottle. A purity percentage is not a measurement of milligrams per capsule or tablet. Use the matching lot report for the measurements actually performed.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy